"



  Psychoactive Plant Database - Neuroactive Phytochemical Collection





Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.

 

Compound Summary

 

PLANT NAME:- Sassafras albidum     PPD ID:- PPD-ID28_106


COMPOUND/COMMON NAME:- myristicin
CAS ID
N/A
INCHI KEY
BNWJOHGLIBDBOB-UHFFFAOYSA-N
MOLECULAR WEIGHT
192.21
MOLECULAR FORMULA
C11H12O3
MOLECULAR MASS
192.214
BIOLOGICAL SOURCE
Sassafras albidum
DATA SOURCE
U.S. Department of Agriculture, Agricultural Research Service. 1992-2016. Dr. Duke's Phytochemical and Ethnobotanical Databases. Home Page, http://phytochem.nal.usda.gov/ http://dx.doi.org/10.15482/USDA.ADC/1239279
CHEMICAL CLASS OF COMPOUND
Benzodioxoles
NLRP3 DOCKING SCORE(Kcal/mol)
-3.753
CANONICAL SMILES   C=CCc1cc(OC)c2c(c1)OCO2
BIOACTIVITY REPORTED FOR NEURODEGENERATIVE DISEASES   No
SYNONYMS
Myristicin, 607-91-0, Myristicine, 6-Allyl-4-methoxy-1,3-benzodioxole, 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole, 5-Allyl-1-methoxy-2,3-(methylenedioxy)benzene, 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)-, Benzene, 5-allyl-1-methoxy-2,3-(methylenedioxy)-, CHEBI:68234, 5-Allyl-2,3-(methylendioxy)anisole, MFCD00133549, 6-allyl-4-methoxybenzo[d][1,3]dioxole, 04PD6CT78W, 4-Methoxy-6-[2-propenyl]-1,3-benzodioxole, DTXSID1025693, 4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole, Myristicin (6CI), CCRIS 6782, HSDB 3516, EINECS 210-146-9, BRN 0166218, UNII-04PD6CT78W, Myristicin_major, 4-methoxy-6-prop-2-enyl-1,3-benzodioxole, MYRISTICIN [MI], MYRISTICIN [HSDB], SCHEMBL68041, 5-19-02-00631 (Beilstein Handbook Reference), MLS001065535, Myristicin, analytical standard, CHEMBL481044, DTXCID605693, HMS2270K14, HY-N2510, Tox21_200172, BDBM50242966, s3291, STK693140, 6-allyl-4-methoxy-benzo-1,3-dioxole, AKOS005604763, CCG-208543, NCGC00091427-01, NCGC00091427-02, NCGC00257726-01, 1ST40367, AC-34678, CAS-607-91-0, DA-75834, MS-23038, SMR000112534, 1-Allyl-3-methoxy-4,5-methylenedioxybenzene, CS-0022781, NS00017756, C10480, 5-Allyl-1-methoxy-2,3-(methylenedioxy)-Benzene, 4-methoxy-6-(prop-2-en-1-yl)-1,3-benzodioxole, Q414057, SR-01000838340, 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole, 9CI, 5-ALLYL-1-METHOXY-2,3-METHYLENEDIOXYBENZENE, 6-ALLYL-1,3-BENZODIOXOL-4-YL METHYL ETHER, SR-01000838340-3, 1-Methoxy-2,3-methylenedioxy-5-(2-propenyl)benzene, 1,3-Benzodioxole, 4-methoxy-6-(2-propenyl)- (9CI)
Back